G&H | ITL

G&H | ITL
Viking House, Ellingham Way
Ashford,  Kent  TN23 6NF

United Kingdom
https://gandh.com/life-sciences-market

• Booth: 1249

G&H provides award-winning medical device design for manufacture services through our G&H | ITL (Integrated Technologies Limited) business. We help pharmaceutical and medical device innovators focus on what they do best while optimizing their go-to-market times and development budgets. Our G&H | ITL business offers specialized contract manufacturing with a global footprint and with operations that are fully compliant with relevant standards and regulations for medical devices.

 Press Releases

• A greener G&H: celebrating the ISO 14001:2015 recommendation for accreditat (Jun 17, 2024)

  The Ashford-based Life Sciences Center of Excellence at G&H has been recommended for accreditation for ISO 14001:2015 in Environmental Management Systems (EMS) by the International Organization for Standardization. This achievement reflects an ongoing effort at Gooch & Housego to implement and maintain corporate sustainability practices that reduce harmful environmental activities and maximize resource efficiency. The manufacturing site has been implementing environmental changes for a number of years to finally be recommended for the accreditation in 2024. This important milestone places G&H as an environmentally conscious business partner, ready to comply with environmental legislation, while also focusing on smart resource management.

  The ISO 14001:2015 is considered to be one of the essential environmental certifications for businesses around the world. As mentioned by the International Organization for Standardization, “In an age of heightened environmental consciousness and increasing global challenges such as climate change, biodiversity loss, and resource depletion, organizations have a pivotal role to play. ISO 14001:2015 offers a structured approach for businesses to address these pressing concerns. By adopting this standard, organizations signal a commitment not only to regulatory compliance but also to ongoing environmental improvement. This proactive approach to environmental management can result in tangible benefits, such as reduced waste, energy conservation, and cost savings. Furthermore, it enhances an organization's reputation, fosters stakeholder trust, and often constitutes a critical step for engaging in global trade and supply chains. Simply put, ISO 14001:2015 stands as a testament to an organization's dedication to a sustainable future, blending environmental responsibility with strategic business growth.”

  At G&H, the path towards environmental awareness and sustainability has been delineated by both product development and dedicated business practices. Working on the innovation front, as well as steering its global corporate environment towards a more eco-friendly outlook, Gooch and Housego has placed the betterment of the world through sustainable impact as one of its main operative goals.

  “We are delighted to have passed the rigorous certification process of the International Organization for Standardization and receive a recommendation for accreditation of ISO 14001:2015 for our business. Our intention has always been to move beyond conversations on sustainability to implementing concrete, actionable steps that show what we stand for. While no framework in this industry is perfect, with each strategic move such as this one geared towards our ecological footprint, G&H gets closer to becoming a greener business partner in a world that cares more and more about its future”, says Isobel Nelson, Health and Safety Officer at G&H | ITL.

  Some of the implemented changes include:

  1. The installation of an initial 184.68 kWp of solar PV, which now has reached 207 kWp in power output;

  2. The instalment of 9 battery systems that capture weekend solar surplus energy, amounting to 57 kW of newly captured green energy;

  3. The implementation of a top-level HVAC system and the removal of oil heating throughout the G&H facility;

  4. The installation of new double-glazed windows throughout the manufacturing site to prevent any potential heat loss;

  5. The introduction of waste stream separation within office environments and a zero-waste-to-landfill recovery which incorporates a full zero-waste hierarchy: prevent, reuse, recycle, recover, and dispose;

  6. The launch of an extensive company cycle-to-work scheme;

  7. The active promotion of car sharing and new work-from-home availability for employees;

  8. The installation of LED lighting for power saving purposes, including a timed lighting system in communal areas;

  9. Adopt best practices from ISO 50001:2018, which translates into conducting yearly Energy Management Audits that ensure an evolution towards the greenhouse gas (GHG) net zero target of 2050.

  More environment-oriented actions are in plan for the optics and photonics leader. Another important manufacturing site (G&H | Stingray in the United States) is working through the audit process with a zero non-conformity report. Also, United Kingdom-based manufacturing locations such as G&H Ilminster and G&H Torquay hold an Eco Energy Supply Certificate awarded by TotalEnergies Gas and Power, which marks an additional step towards environmental accountability at Gooch & Housego.

  The field of optics and photonics bears an important responsibility towards keeping our planet healthy and thriving. On one side, the immense contributions this area can bring through optical technologies span from undersea to outer space management. On the other side, the manner in which processes and products are handled also plays a significant role in making lasting positive changes. With the ISO 14001:2015 recommendation for accreditation of G&H | ITL and the subsequent environment-oriented plans of the company, G&H is showing its reliable commitment towards promoting a greener, healthier future.

• G&H to speak on value delivery of vertical integration at the 2024 Med-Tech (Jun 17, 2024)

  As a leading provider of end-to-end life science solutions, G&H will be present at the 2024 Med-Tech Innovation Expo held at the National Exhibition Centre (NEC) in Birmingham, United Kingdom, between June 5th and 6th. Aside from presenting a generous portfolio of medical technology capabilities, the life sciences company will also emphasize its latest insights into performant med-tech manufacturing, from ideation and prototyping to product maturation and delivery.

  The holistic development of medical devices represents a critical topic for instrument manufacturing. In building innovative, reliable hardware, many decisional layers need to be considered. Typically, within a med-tech collaboration, the involved parties will analyze factors such as the feasibility of the initial design, or the validation and quality control processes of the presented prototypes. What is missing from the overall assessment is the impact of vendor choices on the entire development ecosystem, with visible effects on the final outcome. The clusters affected by vendor choice include the instrument’s functional execution, its patient care integration and overall cost effectiveness. 

  The extensive manufacturing experience pulled in by the G&H group shows that the integration of instrumentation and consumable needs represents a pivotal factor in the medical device development, with positive results across all the above-mentioned clusters. In the current market, most medical device acquisitions involve a split outlook on application interfacing. This approach translates into multiple manufacturers for the creation of a single instrument design. As such, these separated processes are prone to facilitate issues such as regulatory compliance mismatches or consumable incompatibility with the instrument design. Looking at this core problem, the strategic direction at G&H has been to gradually cover 100% of the medical device development cycle and to seamlessly cover all stages of the manufacturing process. Advantages in product quality, delivery time and efficient cost management have been recorded by past med-tech clients at G&H | ITL because of this integrated approach. In particular, the synergy of our US and UK-based manufacturing and design capabilities has led to a considerable improvement in client satisfaction regarding the product development process. 

  To address this market status quo and share these valuable insights, G&H Strategic Business Development Manager Tom Ackrill will be hosting a presentation during the conference on “Driving Smart Solutions: Cost-effective Design Strategies for Manufacturing Success” on June 5th, 2024, at 11:00 a.m. BST at the “Introducing Health Tech” stage.

  “I am excited to attend Med-Tech Innovation Expo because we are getting the chance to explain to a savvy audience why the G&H approach to designing and manufacturing high-end medical devices works. In this industry, quality doesn’t automatically come from just using the latest material components to accommodate different design challenges. Developing a high-performing, reliable piece of equipment within such a life-saving sector happens only when certain critical project conditions are met. This is what we want to focus on throughout our presence in Birmingham at the conference. We have decades of in-house expertise to leverage in this field and the privilege of full vertical integration for our Made-in-the-UK and Made-in-the-US instruments. Looking to our future clients, we want to showcase what they can expect when working with us on their cutting-edge med-tech designs”, says Tom Ackrill, Strategic Business Development Manager at G&H.

  An important emphasis will be placed on the long-term capacity and support offered by G&H in the instrument design process. For questions on the exact capabilities your company can request from G&H, please visit booth #E33 in Hall 22 and talk to one of our specialists on site.

  Driving innovation in such a critical, life-saving sector as med-tech requires a refreshed view on how performance is achieved. Next to continuous R&D developments, the actual processes that shape the final piece of instrumentation need to be brought up to speed to match the growing market demands. This aspect will be amply presented throughout the various Gooch & Housego activities happening in June at the Med-Tech Innovation Expo in Birmingham, United Kingdom. We are looking forward to starting these meaningful conversations for your business there!

• G&H CEO Charlie Peppiatt featured in BioStock, commenting on Prolight Diagn (Jun 17, 2024)

  In April 2024, BioStock featured G&H CEO Charlie Peppiatt and Prolight Diagnostics' Head of Engineering, Paul Monaghan, discussing the progress of their collaboration on the development of Psyros, an innovative point-of-care (POC) system. Prolight Diagnostics has enlisted G&H | ITL for this project, aiming to revolutionize near-patient diagnostics by enabling quick, sensitive, and accurate testing of biomarkers, initially focusing on troponin for myocardial infarction detection.

  Psyros utilizes single-molecule counting technology, a novel approach enabling high sensitivity in biomarker detection. This technology, pioneered by Psyros Diagnostics and acquired by Prolight, counts individual nanoparticles binding to a surface, providing precise measurements from a single drop of blood.

  G&H | ITL is partnering with Prolight for Psyros' development, from concept to manufacturing. In this article, Paul highlights the unique capabilities of the Psyros technology and explains why G&H | ITL was selected for the job as end-to-end manufacturing partner.

  Charlie provides insight into G&H | ITL's project timeline, from developing the compact optical module to prototype instrument development, along with plans for clinical validation studies in 2025.

  “Psyros is ushering in a new era of precision medicine, and we take pride in helping Prolight bring this diagnostic technology to market. This partnership exemplifies our joint commitment to advancing healthcare through cutting-edge innovation.” - Charlie Peppiatt, CEO of G&H